General Otolaryngology
Cost Analysis of Postthyroidectomy Hypocalcemia Jadrien Young, MD (presenter) Objective: One of the more common complications following total thyroidectomy is postoperative hypocalcemia. Numerous protocols have been developed over the years for management including perioperative parathyroid hormone (POPTH) levels and obtaining ionized calcium levels postoperatively with supplementation based on the values. Our goal was to perform a cost analysis of POPTH.
Method:
We examined the postoperative hypocalcemia using ICD-9 codes for thyroid nodules and examined those that underwent total thyroidectomy. We excluded revision surgeries and pathology of cancer. The postoperative PTH values, initial ionized calcium, and number of calcium draws were obtained. The patients were then stratified based on initial PTH value.
Results: For initial PTH For initial PTH 21-50, the initial ionized calcium was 3.99 ± 0.38 and the number of laboratory draws was 3.8 ± 3.3. For initial PTH >50, the initial ionized calcium was 4.27 ± 0.37 and the number of laboratory draws was 2.5 ± 1.7. There was no significant difference in the initial ionized calcium between those that had an initial PTH drawn and those that did not.
Conclusion:
For total thyroidectomies (benign goiter), there was no difference in the initial ionized calcium for PTH90 (P = .29). This suggests that PTH is not an adequate predictor of postoperative calcium level. Also there is a significant cost burden with obtaining the PTH level where tremendous savings could be achieved.
General Otolaryngology
Epidemiology and Burden of Recurrent Acute Rhinosinusitis Neil Bhattacharyya, MD (presenter); Jeff Grebner; Noel G. Martinson Objective: 1) Learn about the epidemiology of recurrent acute rhinosinusitis (RARS). 2) Understand healthcare costs attributable to RARS as a potentially underdiagnosed form of chronic rhinosinusitis.
Method: Medical claims data (2003) (2004) (2005) (2006) (2007) (2008) from a large payer database were analyzed. Adult patients with RARS (defined as at least 4 acute rhinosinusitis [ARS] claims each with a filled oral antibiotic prescription in a 12-month period) were extracted. Diagnostic procedures, surgery rates, and medical costs were determined.
Results: A total of 4,588 patients were identified (mean age, 43.5 years; 72.1% female) among 13.1 million patients, for a point prevalence of 0.035%, which remained consistent across years. After 1, 2, and 4 years, 2.4%, 5.4%, and 9.2% of patients subsequently received nasal endoscopy and 11.4%, 23.5%, and 39.9% received paranasal sinus computed tomography, respectively. Similarly, 0.2%, 2.0%, and 4.1% underwent endoscopic sinus surgery at these same intervals. Average total healthcare costs related to RARS averaged $1207/patient-year. Antibiotic and nasal prescription costs averaged $210 and $452, and an average of 3.8 antibiotics were filled per patient-year with RARS.
Conclusion: RARS may affect approximately 1 in 3000 adults. Despite significant health care costs over $1000/year per individual patient with RARS, nasal endoscopy and computed tomography are not commonly obtained early after potential diagnosis. RARS is likely an underdiagnosed condition warranting further study.
